1 Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 71(3) 209-49.

2 Guan X (2015) Cancer metastases: challenges and opportunities. Acta pharmaceutica sinica B, 5(5) 402-18

3 Siegel RL, Miller KD, Jemal A (2019) Cancer statistics 2019 CA: a cancer journal for clinicians, 69(1) 7-34

4 Kopetz S, Chang GJ, Overman MJ et al. (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. Journal of clinical oncology, 27(22), 3677

5 Sforza V, Martinelli E, Ciardiello F et al. (2016) Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer. World journal of gastroenterology, 22(28), 6345

6 Hönes GS, Rakov H, Logan J et al. (2017) Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo. Proceedings of the National Academy of Sciences, 114(52), E11323-32

7 Ayers S, Switnicki MP, Angajala A, Lammel J, Arumanayagam AS, (2014) Genome-wide binding patterns of thyroid hormone receptor beta. PloS one, 9(2), e81186

8 Nelson M, Hercbergs A, Rybicki L, Strome M. (2006) Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Archives of Otolaryngology–Head & Neck Surgery, 132(10), 1041-46

9 Mondul AM, Weinstein SJ, Bosworth T, Remaley AT, Virtamo J, (2012) Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. PLoS One, 7(10), e47730

10 Vonderhaar BK, Greco AE (1982) Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer research, 42(11), 4553-61

11 Dubnik CS, Morris HP, Dalton AJ (1950) Inhibition of mammary-gland development and mammary-tumor formation in female. Journal of the National Cancer Institute, 10(4), 815-41

12 Vonlaufen A, Wiedle G, Borisch B, Birrer S, (2001) Integrin αvβ3 expression in colon carcinoma correlates with survival. Modern pathology, 14(11), 1126-32

13Cristofanilli M, Yamamura Y, Kau SW et al (2005) Thyroid hormone and breast carcinoma: primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society, 103(6), 1122-28

14 Rostkowska O, Spychalski P, Dobrzycka M et al. (2019) Effects of thyroid hormone imbalance on colorectal cancer carcinogenesis and risk-a systematic review. Endokrynologia Polska, 70(2), 190-7

15 Chan IH, Privalsky ML (2009) Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene, 28(47), 4162-74

16 Plow EF, Haas TA, Zhang L, Loftus J, Smith JW (2000) Ligand binding to integrins. Journal of Biological Chemistry, 275(29), 21785-88

17 Peng C, Zou X, Xia W et al (2018) Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancerassociated fibroblasts. Bioscience Reports, 38(6).

18 Shinderman-Maman E, Cohen K, Weingarten C et al. (2016) The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation. Oncogene, 35(15), 1977-87

19 Cayrol F, Díaz Flaqué MC, Fernando T et al. (2015) Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood, The Journal of the American Society of Hematology, 125(5), 841-851 (2015).

20 Kumar CC, Malkowski M, Yin Z et al.(2001) Inhibition of angiogenesis and tumor growth by SCH221153, a dual αvβ3 and αvβ5 integrin receptor antagonist. Cancer Research, 61(5), 2232-8

21 Mousa SA, O’Connor L, Davis FB, Davis PJ (2006) Proangiogenesis action of the thyroid hormone analog 3, 5- diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology, 147(4), 1602-7

22 Gundersen GG, Worman HJ (2013) Nuclear positioning. Cell, 152(6), 1376-89

23 Parthun M (2007) Hat1: the emerging cellular roles of a type B histone acetyltransferase. Oncogene, 26(37), 5319-28

24 Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Molecular and cellular biology, 21(18), 6091-101

25 Germain P, Chambon P, Eichele G et al. (2006) International union of pharmacology. LXIII. Retinoid X receptors. Pharmacological reviews, 58(4), 760-772

26 Roberts MR, Srinivas M, Forrest D, Morreale de Escobar G, Reh TA (2006) Making the gradient: thyroid hormone regulates cone opsin expression in the developing mouse retina. Proceedings of the National Academy of Sciences, 103(16), 6218-23

27 Liu Y, Xia X, Fondell JD, Yen PM (2006) Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Molecular endocrinology, 20(3), 483-90

28 Davis PJ, Goglia F, Leonard JL. (2016) Nongenomic actions of thyroid hormone. Nature Reviews Endocrinology, 12(2), 111-21

29 Pennacchio LA, Bickmore W, Dean A, Nobrega MA, Bejerano G (2013) Enhancers: five essential questions. Nature Reviews Genetics, 14(4), 288-95

30Cheng S-Y, Leonard JL, Davis PJ (2010) Molecular aspects of thyroid hormone actions. Endocrine reviews, 31(2), 139-70

31 Gauthier K, Flamant F(2014) Nongenomic, TRβ-dependent, thyroid hormone response gets genetic support

32 Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE (2014) Thyroid hormone receptors and resistance to thyroid hormone disorders. Nature Reviews Endocrinology, 10(10), 582-91

33 Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nature Reviews Cancer, 2(2), 91-100

34 Lin HY, Su YF, Hsieh MT et al (2013) Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. The FASEB Journal, 27(8), 3209-16

35 Hiroi Y, Kim H-H, Ying H et al. (2006) Rapid nongenomic actions of thyroid hormone. Proceedings of the National Academy of Sciences, 103(38), 14104-9

36 Bergh JJ, Lin H-Y, Lansing L et al (2005) Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology, 146(7), 2864-71

37 Kinsella J, Sacktor B (1985) Thyroid hormones increase Na+-H+ exchange activity in renal brush border membranes. Proceedings of the National Academy of Sciences, 82(11), 3606-10

38 Dong H, Liu H, Zhou W et al (2019) GLI1 activation by non-classical pathway integrin αvβ3/ERK1/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis. Cell death & disease, 10(8), 1-13

39 Wary KK, Mariotti A, Zurzolo C, Giancotti FG (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell, 94(5), 625-34

40 Kortum RL, Fernandez MR, Costanzo-Garvey DL et al (2014) Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)- mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation. Molecular and cellular biology, 34(18), 3461-72

41 Krashin E, Piekiełko-Witkowska A, Ellis M, Ashur-Fabian O (2019) Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Frontiers in endocrinology, 59.

42 Grespin ME, Bonamy GM, Roggero VR et al (2008) Thyroid hormone receptor α1 follows a cooperative CRM1/calreticulinmediated nuclear export pathway. Journal of Biological Chemistry, 283(37), 25576-88

43 Lin HY, Chin YT, Yang YCS et al. (2011) Thyroid hormone, cancer, and apoptosis. Comprehensive Physiology, 6(3), 1221-37

44 Anyetei-Anum CS, Roggero VR, Allison LA (2018) Thyroid hormone receptor localization in target tissues. Journal of Endocrinology, 237(1), R19-34.

45 Bassett JD, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular and cellular endocrinology, 213(1), 1-11.

46 Yang Z-Y, Di M-Y, Yuan J-Q et al. (2015) The prognostic value of phosphorylated Akt in breast cancer: a systematic review. Scientific reports, 5(1), 1-9.

47 Cheng T-M, Chang W-J, Chu H-Y et al (2021) Nano-strategies targeting the integrin αvβ3 network for cancer therapy. Cells, 10(7), 1684.

48 Shi S, Zhou M, Li X et al. (2016) Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. Journal of Controlled Release, 235, 1-13.

49 Padua D, Zhang XH-F, Wang Q et al. (2008) TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell, 133(1), 66-77.

50 Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ (2005) The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut, 54(9),1283-6

51Brafman D, Willert K (2017) Wnt/β

52 Lee Y-S, Chin Y-T, Yang Y-CS et al (2016) The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status. Steroids, 111, 63-70

53 Liu R, Li Z, Bai S et al (2009) Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Molecular & cellular proteomics, 8(1), 70-85

54 Roberts K, Yokoyama WM, Kehn PJ, Shevach EM (1991) The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. The Journal of experimental medicine, 173(1), 231-40

55 Van der Flier A, Sonnenberg A (2001) Function and interactions of integrins. Cell and tissue research, 305(3), 285-98

56 Silva A, Xiao W, Wang Y et al (2020) Structure–activity relationship of RGD-containing cyclic octapeptide and αvβ3 integrin allows for rapid identification of a new peptide antagonist. International journal of molecular sciences, 21(9), 3076

57 Liu Z, Wang F, Chen X (2008) Integrin αvβ3

58 Columbano A, Simbula M, Pibiri M et al (2008) Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration. Cell proliferation, 41(3), 521-31

59Amin HA, Kamel AM, Radwan DM. The Effect of Tri-iodothyronine on Liver Regeneration .

60 Roehlen N, Crouchet E, Baumert TF (2020) is: mechanistic concepts and therapeutic perspectives. Cells, 9(4), 875

61 Bano A, Chaker L, Muka T et al. (2020) function and the risk of fibrosis of the liver, heart, and lung in humans: a systematic review and meta-analysis. Thyroid, 30(6), 806-20

62 Massagué J (2008) cancer. Cell, 134(2), 215-30

63 Ma G-F, Miao Q, Zeng X-Q et al (2013) growth factor-β1 and-β2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro. PloS one, 8(1), e54249

64 Neel J-C, Humbert L, Lebrun J-J (2012) role of TGFβ in human cancer: from tumor suppression to cancer metastasis. International Scholarly Research Notices

65 Ananiev J, Gulubova M, Tchernev G et al (2011) between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers. Wiener Klinische Wochenschrift, 123(21), 668-73.

66 Candelotti E, De Vito P, G Ahmed R et al (2015) hormones crosstalk with growth factors: Old facts and new hypotheses. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Immunology, Endocrine and Metabolic Agents), 15(1), 71-85

67 Wu S-M, Cheng W-L, Lin CD, Lin K-H (2013) hormone actions in liver cancer. Cellular and Molecular Life Sciences, 70(11), 1915-1936

68 Incerpi S, Davis PJ, Pedersen JZ, Lanni A (2018) mic actions of thyroid hormones. Endocrinology, 259-284

69Manka P, Coombes J, Boosman R, Gauthier K, Papa S, Syn W (2018) hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer letters, 419, 175-186

70 Yen C-C, Huang Y-H, Liao C-Y et al (2006) of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. Journal of molecular endocrinology, 36(1), 9-21 .

71Chetty C, Lakka SS, Bhoopathi P, Rao JS. ( 2010) VEGF expression via αVβ3 integrin

72 Lin H-Y bstract C96: (2015) hormone induced Beta-catenin-dependent proliferation in colorectal cancer cells. Molecular Cancer Therapeutics, 14(12_Supplement_2), C96-C96

73Godugu K, Sudha T, Davis PJ, Mousa SA (2021) Nano Diaminopropane tetrac and integrin αvβ3 expression in different cancer types: Anti-cancer efficacy and Safety. Cancer Treatment and Research Communications, 28, 100395

74 Zoppi N, Gardella R, De Paepe A, Barlati S, Colombi M (2004) Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin. Journal of Biological Chemistry, 279(18), 18157-68